Incyte crosses $1B in quarterly revenue for the 1st time, even as Jakafi faces off against GSK rival aliu Tue, 02/13/2024 – 10:44 More: Incyte crosses B in quarterly revenue for the 1st time, even as Jakafi faces off against
read morePhRMA lawsuit challenging IRA price negotiations dismissed on jurisdictional technicality kdunleavy Tue, 02/13/2024 – 10:11 More: PhRMA lawsuit challenging IRA price negotiations dismissed on jurisdictional technicality Source: fierce
read moreThe projects will focus on healthcare in LMICs in the event of extreme weather More: NIHR awards over £20m to eight new global health research projects Source: News
read moreThe phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359 More: First UK patients receive experimental mRNA therapy for cancer in global trial Source: News
read moreIn wake of Reata buyout, Biogen’s key launch Skyclarys passes muster in EU fkansteiner Mon, 02/12/2024 – 16:57 More: In wake of Reata buyout, Biogen's key launch Skyclarys passes muster in EU Source: fierce
read moreFool me thrice: FDA blasts Chinese API maker for ‘misleading’ investigators, making up testing records fkansteiner Mon, 02/12/2024 – 14:29 More: Fool me thrice: FDA blasts Chinese API maker for 'misleading' investigators, making up testing records Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals